Unknown Heart, Stroke & Blood NIHR-supported project Diabetes, Hormones & Metabolism

Comparison of low-dose and full-dose apixaban in combination with ticagrelor as dual antithrombotic therapy following percutaneous coronary intervention in patients with atrial fibrillation: the LoDAT study

Funder NIHR (part of DHSC)
Recipient organisation NIHR Sheffield Biomedical Research Centre
NIHR support Recorded as supported by this research centre
Period Feb 2025 — Ongoing

About this grant

This summary is based on the grant title only — the full abstract was not available.

No substantive source abstract was published for this research project funded by NIHR.

Researchers

Rob Storey (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Safety and tolerability of adding clopidogrel to aspirin and dipyridamole in patients with acute ischaemic stroke or TIA: a randomised trial
The impact of aspirin dose modification on the innate immune response (Dr William Parker)
The impact of aspirin dose modification, with or without ticagrelor, on the innate immune response - WILL lOWer dose aspirin Therapy ReducE the response to Endotoxin? – (WILLOW TREE).
Non-interventional study on Edoxaban treatment in routine clinical practice for patients with non valvular atrial fibrillation
OPtimal TIMing of Anticoagulation after acute ischaemic Stroke: a randomised controlled trial

Original classification

Cardiovascular Disease

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.